2,778 results on '"Ueno, Naoto"'
Search Results
2. Outcomes of older adults with early-stage triple-negative breast cancer (TNBC) receiving chemotherapy: a single-institution experience
3. Genomic and transcriptomic analyses identify distinctive features of triple-negative inflammatory breast cancer
4. Whole-exome profiles of inflammatory breast cancer and pathological response to neoadjuvant chemotherapy
5. The DNA repair pathway as a therapeutic target to synergize with trastuzumab deruxtecan in HER2-targeted antibody–drug conjugate–resistant HER2-overexpressing breast cancer
6. Altered ribosomal profile in acquired resistance and reversal associates with pathological response to chemotherapy in inflammatory breast cancer
7. TBCRC 039: a phase II study of preoperative ruxolitinib with or without paclitaxel for triple-negative inflammatory breast cancer
8. Analytical and clinical validation of PATHWAY Anti-HER-2/neu (4B5) antibody to assess HER2-low status for trastuzumab deruxtecan treatment in breast cancer
9. Clinical outcomes after 1 versus 2-3 lines of neoadjuvant therapy in stage III inflammatory breast cancer
10. Advances in targets in inflammatory breast cancer
11. Immune checkpoint inhibitors for patients with metastatic triple-negative inflammatory breast cancer (INCORPORATE): An international cohort study
12. Phase 2 study of neoadjuvant enzalutamide and paclitaxel for luminal androgen receptor-enriched TNBC: Trial results and insights into “ARness”
13. Force-Dependent Remodeling of Cell-to-Cell Adhesion Through the Regulation of Phase Separation
14. Targeting chemotherapy resistance in mesenchymal triple-negative breast cancer: a phase II trial of neoadjuvant angiogenic and mTOR inhibition with chemotherapy
15. Comprehensive Analysis Identifies Variability in PI3K Pathway Alterations in Triple-Negative Breast Cancer Subtypes
16. Inflammatory Breast Cancer: Understanding the Patient Experience
17. The immunogram of inflammatory breast cancer
18. Osteoprogenitor-GMP crosstalk underpins solid tumor-induced systemic immunosuppression and persists after tumor removal
19. Lymphedema in Inflammatory Breast Cancer Patients Following Trimodal Treatment
20. Long-term Oncologic Outcomes in Patients with Inflammatory Breast Cancer with Supraclavicular Nodal Involvement
21. Bone Metastases
22. Contributors
23. Differences in Breast Cancer Subtypes among Racial/Ethnic Groups.
24. Ensemble of nucleic acid absolute quantitation modules for copy number variation detection and RNA profiling
25. A gene signature consisting of ubiquitin ligases and deubiquitinating enzymes of SKP2 is associated with clinical outcome in breast cancer
26. Comparative transcriptional analyses of preclinical models and patient samples reveal MYC and RELA driven expression patterns that define the molecular landscape of IBC
27. Phase 1b study of EZH1/2 inhibitor valemetostat in combination with trastuzumab deruxtecan in patients with HER2 low/ultra-low/null metastatic breast cancer.
28. Maintenance pembrolizumab therapy in patients with metastatic HER2-negative breast cancer with prior response to chemotherapy
29. Inflammatory Breast Cancer at the Extremes of Age
30. Somatic mutations reveal asymmetric cellular dynamics in the early human embryo.
31. Rapid Breast Cancer Disease Progression Following Cyclin Dependent Kinase 4 and 6 Inhibitor Discontinuation
32. A 95-gene signature stratifies recurrence risk of invasive disease in ER-positive, HER2-negative, node-negative breast cancer with intermediate 21-gene signature recurrence scores
33. Nonphosphorylatable PEA15 mutant inhibits epithelial-mesenchymal transition in triple-negative breast cancer partly through the regulation of IL-8 expression
34. The Role of Mastectomy in De Novo Stage IV Inflammatory Breast Cancer
35. Update on systemic treatment for newly diagnosed inflammatory breast cancer
36. Chemical generation of small molecule-based bispecific antibody-drug conjugates for broadening the target scope
37. ASO Visual Abstract: Long-Term Oncologic Outcomes in Patients with Inflammatory Breast Cancer with Supraclavicular Nodal Involvement
38. ASO Visual Abstract: Lymphedema in Inflammatory Breast Cancer Patients Following Trimodal Treatment
39. Body composition and breast cancer risk and treatment: mechanisms and impact
40. Bone Metastasis of Breast Cancer
41. Hepatic resection for breast cancer liver metastases: Impact of intrinsic subtypes
42. Author Response: Large-scale animal model study uncovers altered brain pH and lactate levels as a transdiagnostic endophenotype of neuropsychiatric disorders involving cognitive impairment
43. Large-scale animal model study uncovers altered brain pH and lactate levels as a transdiagnostic endophenotype of neuropsychiatric disorders involving cognitive impairment
44. Abstract B013: Understanding the anti-metastatic activity of estrogen receptor β in inflammatory breast cancer
45. Genome evolution in the allotetraploid frog Xenopus laevis
46. Factors Associated with Pathological Node Negativity in Inflammatory Breast Cancer: Are There Patients Who May be Candidates for a De-Escalation of Axillary Surgery?
47. The efficacy of first-line chemotherapy in endocrine-resistant hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2−) metastatic breast cancer
48. Inflammatory breast cancer cells are characterized by abrogated TGFβ1-dependent cell motility and SMAD3 activity
49. Challenges and perspective of drug repurposing strategies in early phase clinical trials
50. Functional consequence of the MET-T 1010I polymorphism in breast cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.